DAR vs. MED, NOMD, BG, INGR, FDP, LMNR, ALCO, ADM, MKC, and USFD
Should you be buying Darling Ingredients stock or one of its competitors? The main competitors of Darling Ingredients include MEDIFAST (MED), Nomad Foods (NOMD), Bunge Global (BG), Ingredion (INGR), Fresh Del Monte Produce (FDP), Limoneira (LMNR), Alico (ALCO), Archer Daniels Midland (ADM), McCormick & Company, Incorporated (MKC), and US Foods (USFD).
Darling Ingredients vs. Its Competitors
Medifast (NYSE:MED) and Darling Ingredients (NYSE:DAR) are both consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.
Darling Ingredients has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Darling Ingredients, indicating that it is currently the more affordable of the two stocks.
Darling Ingredients has a net margin of 3.02% compared to Medifast's net margin of -1.29%. Medifast's return on equity of 6.63% beat Darling Ingredients' return on equity.
Medifast has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, Darling Ingredients has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500.
In the previous week, Darling Ingredients had 18 more articles in the media than Medifast. MarketBeat recorded 20 mentions for Darling Ingredients and 2 mentions for Medifast. Darling Ingredients' average media sentiment score of 1.63 beat Medifast's score of 0.76 indicating that Darling Ingredients is being referred to more favorably in the news media.
95.5% of Medifast shares are owned by institutional investors. Comparatively, 94.4% of Darling Ingredients shares are owned by institutional investors. 2.9% of Medifast shares are owned by company insiders. Comparatively, 2.6% of Darling Ingredients shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Medifast presently has a consensus price target of $16.50, suggesting a potential upside of 14.03%. Darling Ingredients has a consensus price target of $46.14, suggesting a potential upside of 23.01%. Given Darling Ingredients' stronger consensus rating and higher possible upside, analysts plainly believe Darling Ingredients is more favorable than Medifast.
Summary
Darling Ingredients beats Medifast on 13 of the 17 factors compared between the two stocks.
Get Darling Ingredients News Delivered to You Automatically
Sign up to receive the latest news and ratings for DAR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding DAR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Darling Ingredients Competitors List
Related Companies and Tools
This page (NYSE:DAR) was last updated on 7/12/2025 by MarketBeat.com Staff
